Permeability Enhancement

Permeability Enhancement is a prodrug design strategy in which the parent drug’s molecular structure is transiently modified (typically via reversible promoieties) to increase its ability to traverse biological barriers such as epithelial or endothelial membranes, thereby improving its absorption and bioavailability.

1.7K

Publications

95.7K

Citations

7.1K

Authors

1.7K

Institutions

Publications per year

2017–2026

376

Authors

7.1K

  1. AB
    Andreas Bernkop‐Schnürch

    Universität Innsbruck, Austria

    18 publications · 786 citations

    16

    h-index

  2. KV
    Kateřina Vávrová

    Charles University, Czechia

    16 publications · 504 citations

    14

    h-index

  3. WI
    William I. Higuchi

    University of Utah, United States

    13 publications · 497 citations

    13

    h-index

  4. AH
    Alexandr Hrabálek

    Charles University, Czechia

    13 publications · 381 citations

    12

    h-index

  5. LF
    Liang Fang

    Shenyang Pharmaceutical University, China

    13 publications · 402 citations

    12

    h-index

1–5 of 7.1K

Venues

  1. International Journal of Pharmaceutics

    114 publications · 5.4K citations

    44

    h-index

  2. Journal of Controlled Release

    55 publications · 3.4K citations

    35

    h-index

  3. Journal of Pharmaceutical Sciences

    57 publications · 3.3K citations

    32

    h-index

  4. Pharmaceutical Research

    44 publications · 3K citations

    31

    h-index

  5. PubMed

    Repository · 78 publications · 3.7K citations

    28

    h-index

1–5